Allgens Medical Technology Full Year 2023 Earnings EPS CN0.40 - Simply Wall St
688613 Stock | 17.15 0.16 0.94% |
About 51% of Allgens Medical's investors are presently thinking to get in. The analysis of overall sentiment of trading Allgens Medical Technology stock suggests that some investors are interested at this time. The current market sentiment, together with Allgens Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Allgens Medical Tech stock news signals to limit their universe of possible portfolio assets.
Allgens |
Allgens Medical Technology Full Year 2023 Earnings EPS CN0.40 Simply Wall St
Read at news.google.com
Allgens Medical Fundamental Analysis
We analyze Allgens Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Allgens Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Allgens Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Allgens Medical is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Allgens Medical Tech Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Allgens Medical stock to make a market-neutral strategy. Peer analysis of Allgens Medical could also be used in its relative valuation, which is a method of valuing Allgens Medical by comparing valuation metrics with similar companies.
Peers
Allgens Medical Related Equities
200468 | Nanjing Putian | 2.68 | ||||
300013 | Jiangsu Xinning | 0.52 | ||||
002168 | Shenzhen Hifuture | 0.36 | ||||
000692 | Shenyang Huitian | 0.80 | ||||
600322 | Tianjin Realty | 1.69 | ||||
600462 | Hubei Geoway | 1.99 |
Complementary Tools for Allgens Stock analysis
When running Allgens Medical's price analysis, check to measure Allgens Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allgens Medical is operating at the current time. Most of Allgens Medical's value examination focuses on studying past and present price action to predict the probability of Allgens Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allgens Medical's price. Additionally, you may evaluate how the addition of Allgens Medical to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |